Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$3.61 - $5.45 $1.62 Million - $2.44 Million
-448,000 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$3.14 - $6.14 $127,763 - $249,830
-40,689 Reduced 8.33%
448,000 $1.76 Million
Q4 2020

Feb 02, 2021

SELL
$1.79 - $4.04 $16,826 - $37,976
-9,400 Reduced 1.89%
488,689 $1.53 Million
Q3 2020

Nov 05, 2020

BUY
$1.56 - $2.08 $41,652 - $55,536
26,700 Added 5.66%
498,089 $936,000
Q2 2020

Aug 12, 2020

BUY
$0.94 - $2.21 $147,043 - $345,708
156,429 Added 49.67%
471,389 $825,000
Q4 2019

Jan 27, 2020

BUY
$1.14 - $1.49 $228,177 - $298,232
200,156 Added 174.35%
314,960 $406,000
Q3 2019

Oct 31, 2019

BUY
$1.04 - $1.44 $9,701 - $13,432
9,328 Added 8.84%
114,804 $144,000
Q2 2019

Aug 15, 2019

SELL
$1.09 - $1.88 $121,118 - $208,901
-111,118 Reduced 51.3%
105,476 $121,000
Q1 2019

May 03, 2019

BUY
$1.14 - $2.25 $147,668 - $291,451
129,534 Added 148.79%
216,594 $427,000
Q4 2018

Feb 08, 2019

SELL
$1.02 - $2.05 $6,108 - $12,277
-5,989 Reduced 6.44%
87,060 $92,000
Q2 2018

Aug 15, 2018

BUY
$1.59 - $2.38 $9,522 - $14,253
5,989 Added 6.88%
93,049 $177,000
Q3 2017

Nov 15, 2017

BUY
$1.15 - $2.29 $100,118 - $199,367
87,060
87,060 $189,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.55B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.